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Research Article
A dual role for SAMHD1 in regulating HBV cccDNA
and RT-dependent particle genesis
Peter AC Wing1 , Tamara Davenne2, Jochen Wettengel3, Alvina G Lai1 , Xiaodong Zhuang1, Anindita Chakraborty3,
Valentina D’Arienzo1, Catharina Kramer1, Chunkyu Ko3, James M Harris1, Sabrina Schreiner3,4, Martin Higgs5 ,
Stephanie Roessler6 , Joanna L Parish5 , Ulrike Protzer3,4 , Peter Balfe5 , Jan Rehwinkel2 , Jane A McKeating1
Chronic hepatitis B is one of the world’s unconquered diseases
with more than 240 million infected subjects at risk of developing
liver disease and hepatocellular carcinoma. Hepatitis B virus
reverse transcribes pre-genomic RNA to relaxed circular DNA
(rcDNA) that comprises the infectious particle. To establish in-
fection of a naı¨ve target cell, the newly imported rcDNA is
repaired by host enzymes to generate covalently closed circular
DNA (cccDNA), which forms the transcriptional template for viral
replication. SAMHD1 is a component of the innate immune system
that regulates deoxyribonucleoside triphosphate levels required
for host and viral DNA synthesis. Here, we show a positive role for
SAMHD1 in regulating cccDNA formation, where KO of SAMHD1
signiﬁcantly reduces cccDNA levels that was reversed by expressing
wild-type but not amutated SAMHD1 lacking the nuclear localization
signal. The limited pool of cccDNA in infected Samhd1 KO cells is
transcriptionally active, and we observed a 10-fold increase in newly
synthesized rcDNA-containing particles, demonstrating a dual role
for SAMHD1 to both facilitate cccDNA genesis and to restrict reverse
transcriptase-dependent particle genesis.
DOI 10.26508/lsa.201900355 | Received 21 February 2019 | Revised 15 March
2019 | Accepted 18 March 2019 | Published online 27 March 2019
Introduction
Chronic hepatitis B is one of the world’s most economically im-
portant diseases, with 2 billion people exposed to the virus at some
stage of their lives. Hepatitis B virus (HBV) replicates in the liver, and
chronic infection can result in progressive liver disease, cirrhosis,
and hepatocellular carcinoma. HBV is the third leading cause of
cancer-related deaths, with an estimated mortality of 695,000
deaths per year (Ringelhan et al, 2017). HBV is the prototypic
member of the hepadnaviruses, a family of small enveloped hep-
atotropic viruses with a partial double-stranded relaxed circular DNA
(rcDNA) genome. Following infection, the rcDNA is imported to the
nucleus and converted to covalently closed circular DNA (cccDNA)
that serves as the transcriptional template for viral RNAs. The
rcDNA represents the mature form of the viral genome that is
packaged into nucleocapsids that are enveloped and released as
newly formed infectious virions or redirected toward the nucleus
to replenish and maintain the pool of episomal cccDNA. This
ampliﬁcation pathway, together with the long half-life of cccDNA
contributes to viral persistence (Urban et al, 2010; Ko et al, 2018).
HBV does not require integration into the host genome for rep-
lication; however, integrated viral DNA fragments are commonly
found in chronic hepatitis B and may contribute to carcinogenesis
(Tu & Urban, 2018).
The mechanisms underlying HBV rcDNA repair and early steps in
cccDNA formation are not well deﬁned (Schreiner & Nassal, 2017)
and several members of the host DNA repair pathway are reported
to play a role. Tyrosyl-DNA phosphodiesterase 2 (TDP-2) cleaves the
topoisomerase-like linkage between the polymerase and rcDNA
(Koniger et al, 2014; Cui et al, 2015); ﬂap endonuclease (FEN1) excises
the overlapping regions in rcDNA (Kitamura et al, 2018) together
with the polymerases κ and λ (Qi et al, 2016) and ligases LIG1 and
LIG3 (Long et al, 2017) that repair and ligate the incomplete rcDNA
regions, respectively. HBV cccDNA copy number in the chronically
infected liver, in vitro culture systems, and infected chimeric liver
mice is low (Werle-Lapostolle et al, 2004; Volz et al, 2013; Nassal,
2015) and not affected by the currently used nucleoside and nu-
cleotide analogue therapies that only suppress HBV replication.
Hence, a greater understanding of the host pathways regulating
HBV cccDNA formation will aid the development of curative
treatments that will eliminate or permanently silence this episomal
DNA reservoir.
Sterile alpha motif and histidine–aspartic acid domain con-
taining protein 1 (SAMHD1) is a deoxyribonucleoside triphosphate
(dNTP) triphosphohydrolase (Goldstone et al, 2011; Powell et al,
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2011) that restricts HIV-1 infection of myeloid cells and CD4+ T cells
by depleting dNTPs required for reverse transcription (Hrecka et al,
2011; Laguette et al, 2011; Baldauf et al, 2012; Lahouassa et al, 2012).
HBV replication is dependent on reverse transcription during a late
step in its life cycle where encapsidated pre-genomic RNA (pgRNA)
is converted to rcDNA by the viral encoded polymerase (Urban et al,
2010). Sommer et al reported a restrictive role for SAMHD1 in HBV
reverse transcription where siRNA knockdown (KD) induced a
modest twofold increase in secreted HBV particles (Sommer et al,
2016). Viruses generally evolve to evade or counteract host re-
striction factors, for example, lentiviral accessory proteins Vpx and
Vpr target SAMHD1 for proteasomal degradation via the E3 cellular
ubiquitin ligase complex (Laguette et al, 2011; Lim et al, 2012). HBV
infection does not degrade SAMHD1 (Sommer et al, 2016), sug-
gesting additional roles for SAMHD1 in the viral life cycle.
Mutations in SAMHD1 are implicated in cancer development
(Mauney & Hollis, 2018) and in a severe congenital inﬂammatory
disease known as Aicardi–Goutières syndrome that is characterized
by an overproduction of type I IFNs (Crow & Manel, 2015). Recent
reports highlight a role for SAMHD1 to regulate DNA repair in-
dependent of its dNTPase activity (Goncalves et al, 2012; Tungler et al,
2013; Seamon et al, 2015; Seamon et al, 2016; Daddacha et al, 2017).
SAMHD1 can interact with the Mre11 exonuclease and stimulate its
activity (Coquel, Neumayer et al, 2018a), suggesting a scaffolding role
for SAMHD1 in coordinating the activity of the DNA replisome (Pasero
& Vindigni, 2017). In SAMHD1-depleted cells, single-stranded DNA
fragments are released from stalled replication forks and accumu-
late in the cytosol, where they activate the cyclic GMP-AMP synthase
(cGAS)–stimulation of interferon genes (STING) pathway to induce
expression of pro-inﬂammatory type I IFNs (Coquel, Silva et al, 2018b).
Here, we show two distinct roles for SAMHD1 in the HBV life cycle.
First, SAMHD1 is required during the early steps of cccDNA for-
mation. Second, using Samhd1 KO hepatoma cells, we observed a
signiﬁcant 1–2 log increase in newly synthesized and secreted HBV
DNA particles. Our studies highlight a dual role for SAMHD1, both as
a host-dependency factor and as a restriction factor, depending on
the stage in the HBV life cycle.
Results
SAMHD1 positively regulates HBV cccDNA levels
HBV preferentially infects nondividing hepatocytes in the liver and
in vitro culture systems use DMSO to both arrest cells and induce
the expression of liver-speciﬁc differentiation factors required for
viral replication. We used HepG2-NTCP (K7) cells as they support
efﬁcient HBV replication (Ko et al, 2018) and express basal levels of
SAMHD1 and its phosphorylated form (P-SAMHD1) (Fig 1A). We
conﬁrm that SAMHD1 is induced by IFNs, consistent with previous
reports (Berger et al, 2011) (Fig 1A). Moreover, screening a panel of
human hepatocyte-derived cells showed that all lines expressed
basal levels of SAMHD1 in the absence of IFN treatment (Fig S1).
Thus, HepG2-NTCP cells recapitulate the IFN-dependent regulation
of SAMHD1 reported in the literature.
The Vpx proteins of the SIVSMM/HIV-2 lentiviruses bind SAMHD1
and recruit the E3 ubiquitin ligase that targets SAMHD1 for pro-
teasomal degradation (Laguette et al, 2012; Lim et al, 2012). To
exploit this, we used lentivirus-like particles (LVPs) containing Vpx
Figure 1. Vpx-targeted degradation of SAMHD1 in HepG2-NTCP reduces HBV cccDNA levels.
(A) HepG2-NTCP cells were arrested with 2% DMSO 3 d before treating with IFNa (1,000 IU/ml) for 24 h. Levels of total and phosphorylated SAMHD1 were assessed by
Western blot. (B) HepG2-NTCP cells were transduced with Vpx-LVPs and infected with HBV at an MOI of 200 for 6 d. DNA extracted after HIRT lysis was analyzed by
Southern blotting using an HBV-speciﬁc probe. Size markers of a known length were run as a control. Numbers below the blot indicate densitometric values for cccDNA ±
Vpx-LVP transduction. Vpx knockdown of SAMHD1 was conﬁrmed by Western blotting. (C) HepG2-NTCP cells were transduced with Vpx-LVPs or supplemented with 0.5 mM
dN 24 h before infection with HBV at an MOI of 200 genome equivalents (GEs). cccDNA levels were quantiﬁed at 3 d postinfection by qPCR. In addition, HepG2-NTCP
cells were infected as before with Vpx-LVPs delivered 3 d postinfection. The cells were cultured for a further 3 d and harvested for cccDNA quantiﬁcation by qPCR.
Data represent two independent experiments, each comprising three replicates per condition and are presented asmean ± SEM. Statistical analysis was performed using a
Mann–Whitney U test (*P ≤ 0.05).
Source data are available for this ﬁgure.
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to degrade SAMHD1 at deﬁned times to investigate its role in HBV
replication. Vpx reduced SAMHD1 expression in HepG2-NTCP, and
infecting these cells with HBV resulted in signiﬁcantly lower levels
of cccDNA as measured by Southern blotting and PCR (Fig 1B and C),
suggesting that SAMHD1 may play a pro-viral role in the estab-
lishment of the HBV transcription template. Importantly, providing
exogenous pyrimidine and purine deoxynucleosides (dNs) to
HepG2-NTCP cells had no effect on cccDNA levels, suggesting that
HBV cccDNA formation is not limited by dNTP levels (Fig 1C). To
establish when SAMHD1 regulates HBV cccDNA levels, we infected
cells with HBV and 3 d later, transduced with LVP-Vpx andmeasured
cccDNA levels after a further 3 d (i.e., 6 d post HBV infection). Al-
though the KD of SAMHD1 was efﬁcient in the HBV-infected cells, we
observed a negligible effect on cccDNA levels (Fig 1C), suggesting
that SAMHD1 is required during the early stages of cccDNA
formation.
To extend these observations, we used CRISPR-Cas9 to KO SAMHD1
in HepG2 NTCP cells. Western blotting (Fig 2A) and genome sequencing
identiﬁed two KO clones U8 and U12. In line with previous reports, we
demonstrate increased dNTP levels in both KO clones compared with
Wt cells (Fig 2B), with a signiﬁcant increase in dGTP compared with
other dNTPs (Franzolin et al, 2013). Moreover, to conﬁrm that Samhd1
KO cells were deﬁcient in regulating DNA resection during double-
stranded break (DSB) repair (Daddacha et al, 2017), we treated Wt and
KO (clone 8) HepG2 NTCP cells with the topoisomerase inhibitor
camptothecin (CPT) to induce DSBs and assessed resection levels.
These analyses showed a signiﬁcant reduction in the level of phos-
phorylated RPA32 foci, amarker of resected DNA after DSB repair, in KO
Figure 2. Samhd1 KO in HepG2-NTCP cells reduces
HBV cccDNA.
(A) HepG2-NTCP cells were transfected with guide RNAs
for CRISPR-Cas9 KO of Samhd1 and single colonies
obtained by limiting dilution. The colonies were
ampliﬁed and screened for SAMHD1 expression by
Western blot. (B) Extracts were prepared from parental
and Samhd1 KO clones U8 and U12 and dNTP levels
measured. Data are shown relative to total cellular
protein and represent two independent experiments,
each comprising three replicates per condition and
presented as mean ± SEM. (C) NTCP expression in
Samhd1 KO HepG2-NTCP clones U8 and U12 was tested
using Myrcludex B (MyrB) tagged with an Alexa 488
ﬂuorophore. Huh-7.5 cells (NTCP negative) were used as
a control. Images were taken on a 20× objective; scale
bar depicts 20 μm. (D) HBV uptake in Wt and Samhd1 KO
U8. HepG2-NTCP Wt and Samhd1 KO U8 cells were
infected with HBV for 6 h using a synchronized infection
protocol (see the Materials and Methods section) and
total HBV DNA levels quantiﬁed by qPCR. Data are shown
relative to Wt cells. As a control to block HBV entry, the
cells were treated with heparin (50 IU/ml) for 1 h before
infection. Data represent two independent experiments,
each comprising three replicates per condition and are
presented as mean ± SEM. Statistical analysis was
performed using a Mann–Whitney U test. (E) HepG2-
NTCPWt and Samhd1 KO U8 cells were infected with HBV
at an MOI of 200 for 6 h and cccDNA levels determined at
3 d postinfection by qPCR. Data are shown relative to Wt
cells and represent three independent experiments,
each comprising three replicates per condition and are
presented as mean ± SEM. Statistical analysis was
performed using a Mann–Whitney U test (***P ≤ 0.001).
DNA extracted from infected Wt and SAMHD1 KO cells
was analyzed by Southern blotting using an HBV-
speciﬁc probe. Size markers of a known length were run
as a control. Numbers below the blot indicate
densitometric values for cccDNA in Wt and KO cells. (F)
Parental and Samhd1 KO U8 cells were transduced with
Vpx-LVP 24 h before HBV infection. The cells were
infected with HBV at an MOI of 200 for 3 d after which
cccDNA was quantiﬁed by qPCR. Data represent two
independent experiments, each comprising three
replicates per condition and presented as mean ± SEM.
Statistical analysis was performed using a
Mann–Whitney U test (*P ≤ 0.05). (G) Infection of Wt and
Samhd1 KO U8 cells with a single-cycle HBV-Gaussia
reporter virus (HBV-Gluc). The cells were infected with HBV-Gluc at an MOI of 200 and luciferase activity measured 24 h postinfection. The cells treated with the entry
inhibitor MyrB (1 μM) acted as a control for background luciferase signal. Data represent two independent experiments, each comprising three replicates per condition and
are presented as mean ± SEM. Statistical analysis was performed using a Mann–Whitney U test (**P ≤ 0.01).
Source data are available for this ﬁgure.
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cells compared with Wt (Fig S2). Because Sodium Taurocholate
Cotransporting Polypeptide (NTCP) is essential for HBV entry, we
conﬁrmed that bothSamhd1 KO clones express the viral receptor using
a ﬂuorescent-labelled HBV Pre-S1 peptide mimetic that binds NTCP
(Myrcludex B) (Fig 2C). Thus, our KO cells recapitulate the reported
phenotype of cells depleted of SAMHD1 and provide an idealmodel for
studying its role in the HBV life cycle.
We used a recently developed synchronized infection assay that
measures HBV cellular uptake (Ko et al, 2018) to determine the effect of
SAMHD1 on viral entry. We noted comparable levels of virus in-
ternalization into Wt and Samhd1 KO cells during a short-term 6-h
infection assay (Fig 2D). As a positive control, we demonstrated that
heparin blocked the viral uptake as previously reported (Ko et al, 2018;
Schulze et al, 2007). Importantly, we noted a signiﬁcant reduction in
cccDNA levels in the Samhd1 KO cells compared to Wt at 3 d post-
infection (Figs 2E and S3), consistent with our earlier data using Vpx-
mediated degradation of SAMHD1. To exclude the possibility that Vpx
may have additional effects on host cellular pathways, we transduced
Samhd1 KO cells with Vpx-LVPs and reassuringly this showed no ad-
ditional effect on cccDNA levels (Fig 2F). In an effort to study the role of
SAMHD1 in cccDNA formation at earlier time points following infection,
we used a recombinant HBV reporter virus encoding Gaussia luciferase
(rHBV-Gaussia) where luminescence is dependent on cccDNA forma-
tion (Untergasser & Protzer, 2004). We observed a signiﬁcant reduction
in Gaussia activity in the Samhd1 KO cells at 24 h postinfection (Fig 2G),
conﬁrming our earlier observations that SAMHD1 positively regulates
early steps in cccDNA formation and/or maintenance.
SAMHD1 is a nuclear protein that preferentially uses karyopherin
α2 and a classical N-terminal nuclear localization signal (NLS) to
trafﬁc to the nucleus (Schaller, Pollpeter et al, 2014a). To investigate
the role of SAMHD1 nuclear localization in HBV cccDNA genesis, we
transduced Samhd1 KO cells with lentiviruses expressing HA-
tagged Wt or K11A SAMHD1 mutated in the NLS (Schaller et al,
2014a). We conﬁrmed cytoplasmic localization of SAMHD1K11A (Fig
3A) and a signiﬁcant reduction in cellular dGTP and dATP levels,
conﬁrming catalytic activity of the NLS mutant (Fig 3B). Importantly,
Wt SAMHD1 restored the cccDNA copy number to comparable levels
seen in Wt HepG2-NTCP cells; however, SAMHD1K11A had a minimal
effect on cccDNA levels (Fig 3C), demonstrating a role for nuclear
SAMHD1 in the early steps of HBV cccDNA formation.
SAMHD1 can promote the degradation of nascent DNA at stalled
replication forks, resulting in the accumulation of single-stranded
DNA fragments that activate the cGAS–STING pathway and induce
IFNs (Coquel et al, 2018b). APOBEC3 (A3) cytidine deaminases are a
family of IFN stimulated enzymes that can degrade cccDNA and
inhibit HBV replication (Lucifora et al, 2014). We investigated whether
HBV infection of Wt or Samhd1 KO cells induced the expression of
APOBECs along with MxA and ISG20 following a 6-h synchronized
infection. Interestingly, we observed a signiﬁcant increase in MxA,
ISG20, and APOBEC mRNA levels in HBV-infected KO cells compared
with Wt (Fig 4) that was dependent on HBV internalization, suggesting
that SAMHD1 acts to suppress innate immune activation.
SAMHD1 restricts de novo HBV particle genesis
HBV replication is deﬁned by the size and transcriptional output of
the cellular cccDNA pool, and we were interested to know whether
SAMHD1 could regulate cccDNA transcriptional activity. PCR
quantiﬁcation of pgRNA levels at 6 d postinfection of Wt, and
Samhd1 KO cells showed comparable levels of viral transcripts
relative to cccDNA levels in both cell types (Fig S4), suggesting a
minimal role for SAMHD1 in modulating cccDNA epigenome and
associated transcriptional activity.
SAMHD1 was previously reported to limit the de novo genesis of
encapsidated rcDNA particles, where siRNA silencing of SAMHD1
induced a modest twofold increase in the secretion of HBV DNA
from the stable HBV producer line HepG2.2.15 (Chen et al, 2014;
Sommer et al, 2016). We show that Vpx-mediated KD of SAMHD1 in
HepG2.2.15 resulted in a 20-fold increase in extracellular HBV DNA
levels when the cells were pretreated with the nucleoside analog
entecavir (ETV) (Fig 5A). In contrast, we observed a modest non-
signiﬁcant effect of SAMHD1 KD in HepG2.2.15 cells without prior ETV
treatment, most likely reﬂecting the accumulation and long half-life
of intracellular encapsidated rcDNA genomes in this producer cell
line (Fig 5A). We conﬁrmed that treating HepG2.2.15 cells with ETV
reduced extracellular HBV DNA levels and removing the drug by
extensive washing reversed this inhibition and allowed one to
observe reverse transcriptase (RT) dependent particle genesis (Fig
S5). Applying this ETV pretreatment and “wash-out” protocol to an
independent HBV producer line HepAD38 (Ladner et al, 1997)
showed that Vpx-mediated KD of SAMHD1 induced a 10-fold in-
crease in HBV DNA levels (Fig S6). We sought to validate these
results in de novo–infected HepG2-NTCP cells and found that Vpx-
mediated degradation of SAMHD1 signiﬁcantly increased the levels
of extracellular HBV DNA above the ETV control (Fig 5B). Adenoviral
vectors encoding HBV genomes (Ad-HBV) have been used exten-
sively to deliver the HBV transcriptional template to cells and
support robust particle assembly (Huang et al, 2012), allowing us to
focus on the late steps of the viral life cycle. Ad-HBV-GFP–
transduced HepG2-NTCP cells secrete HBV DNA in an RT-dependent
manner (Fig S7), and Vpx-KD of SAMHD1 resulted in the secretion of
11-fold more particles (Fig 5C). Furthermore, repeating this exper-
iment in our Samhd1 KO cells showed a robust phenotype with a
100-fold increase in secreted HBV particles enabling us to quantify
particle production over time (Fig 5D). In line with reports that
SAMHD1 restricts HIV replication, we conﬁrm a signiﬁcant increase
in HIV RT-dependent replication in our Samhd1 KO hepatoma cells
(Fig S8). In summary, we show that SAMHD1 restricts the genesis of
HBV DNA-containing particles.
Discussion
Our study highlights a dual role for SAMHD1 in the HBV life cycle, a
positive role in regulating cccDNA levels and a restriction of
polymerase-mediated reverse transcription of pgRNA to rcDNA.
Since our experiments focus on the ﬁrst 3 d of infection and cccDNA
is long-lived with an estimated half-life of 40 d in vitro (Ko et al,
2018), we are unable to assess the role of SAMHD1 in cccDNA
maintenance. To the best of our knowledge, this is the ﬁrst ob-
servation describing a pro-viral role for SAMHD1 and is consistent
with reports on the role of SAMHD1 in DNA repair (Coquel et al,
2018a). SAMHD1 phosphorylation, mediated by cyclin-dependent
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kinases CDK1 and CDK2 (St Gelais, 2014), is required for the resection
of nascent DNA strands at stalled replication forks (Daddacha et al,
2017) and may act as a switch between the nuclease and dNTPase
functions that regulate HBV cccDNA genesis and de novo particle
genesis, respectively (Fig 6).
Upon infection, the HBV capsid is transported to the nucleus
where the rcDNA is released and repaired to generate cccDNA. HBV
rcDNA has both strand breaks and single-stranded regions that
require trimming, elongation, and ligation, and several members of
the DNA damage response pathway have been reported to mediate
these processes (Schreiner & Nassal, 2017). The identiﬁcation of
alternative enzymes for many of the functions required for cccDNA
genesis suggests functional redundancy within the DNA repair
system (reviewed in Mayanagi et al (2018)). SAMHD1 can bind ssDNA
and has been reported to act as a scaffolding protein to promote
both homologous recombination and DNA resection (Goncalves
et al, 2012; Beloglazova et al, 2013; Tungler et al, 2013; Seamon et al,
2015, 2016; Daddacha et al, 2017), functions that may account for its
stimulatory role in the rcDNA repair process. At the present time,
our experiments cannot discriminate whether SAMHD1 regulates
the half-life of incoming rcDNA particles or speciﬁcally binds HBV
DNA template. Our observation that mutation of the NLS of SAMHD1
did not restore cccDNA levels in HBV-infected Samhd1 KO cells,
while modulating cellular dNTP levels, demonstrate a requirement
for nuclear SAMHD1 that is independent of its dNTPase activity. This
observation is consistent with reports that SAMHD1-depleted cells
show impaired DNA replication fork progression (Franzolin et al,
2013; Rentoft et al, 2016).
The innate immune system is the ﬁrst line of host defense
against a broad range of pathogens, including viruses and cellular
stress by sensing damage-associated molecular patterns, including
cytosolic DNA. This DNA is recognized by a variety of nucleic acid
sensors that converge on STING to transactivate innate immune
response genes (Dhanwani et al, 2018). A key player in this process
is cGAS that is triggered by cytosolic DNA accumulating after ion-
izing radiation (Hartlova et al, 2015) or by exposure to agents
targeting DNA replication forks (Yang et al, 2007; Lam et al, 2014;
Shen et al, 2015). Importantly, we show that HBV infection of Samhd1
KO cells induces several genes of the innate immune system (MxA,
ISG20, and APOBECs), and it is noteworthy that APOBEC3A and 3B
have been reported to degrade cccDNA levels in HBV-infected
hepatocytes (Lucifora et al, 2014). The negligible induction of any
Figure 3. Nuclear localization of SAMHD1 is required for HBV cccDNA genesis.
(A) Immunoﬂuorescent images of Samhd1 KO clone U8 cells transduced with
lentivirus expressing HA-tagged SAMHD1 Wt or K11A mutant . Images were taken
using an X63 objective; scale bars indicate 50 μm. (B) HepG2-NTCP Samhd1 KO U8
cells were transduced with lentivirus expressing HA-tagged Wt or SAMHD1K11A for
24 h. Expression was conﬁrmed by Western blotting and dNTP levels quantiﬁed.
dNTP levels were normalized to total cellular protein. Data from two independent
experiments are shown as mean ± SEM. Statistical analysis was performed using a
Mann–Whitney U test (*P ≤ 0.05). (C) HepG2-NTCP Samhd1 KO U8 cells were
transduced with lentivirus expressing Wt or SAMHD1K11A and 24 h later infected
with HBV at an MOI of 200. cccDNA was quantiﬁed by qPCR at 3 d postinfection and
SAMHD1 expression conﬁrmed by Western blotting. Data represent two
independent experiments, each comprising three replicates per condition and are
presented as mean ± SEM. Statistical analysis was performed using a
Mann–Whitney U test (*P ≤ 0.05).
Source data are available for this ﬁgure.
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ISGs in HBV-infected Wt HepG2-NTCP cells is consistent with earlier
reports describing HBV as a “stealth” virus that does not induce IFN
responses in chimpanzees (Wieland et al, 2004), acutely infected
patients (Dunn et al, 2009; Stacey et al, 2009), or in vitro infection
models (Cheng et al, 2017; Niu et al, 2017; Mutz et al, 2018). These
results highlight a potential new role for SAMHD1 in regulating host
innate recognition of HBV genomes that may restrict the cccDNA
reservoir in vivo. The interplay between DNA damage response
factors, including SAMHD1, and innate immune sensors is not well
deﬁned and further studies to deﬁne pathways regulating the
stability of incoming HBV rcDNA particles and trafﬁcking to the
nucleus are required to understand the complex mechanisms
underlying cccDNA genesis and maintenance.
Using a variety of HBV model systems, we demonstrate that Vpx-
targeted degradation or genetic KO of SAMHD1 results in a sig-
niﬁcant 10-fold to 100-fold increase in secreted HBV DNA. This
contrasts with the modest twofold increase in secreted encapsi-
dated viral DNA previously reported (Chen et al, 2014; Jeong et al,
2016; Sommer et al, 2016). These differences may reﬂect the use of
siRNA that only partially suppressed Samhd1 mRNA levels or the
Figure 4. HBV activation of innate immune responses
in Samhd1 KO cells.
MxA, ISG20, Apobec 3A, 3B, 3C, 3D, 3F, and 3G RNA levels
were measured by RT-qPCR in Wt and Samhd1 KO U8
cells that were infected with HBV for 6 h using a
synchronized infection protocol (Fig 2D). As a control,
transcript levels weremeasured in heparin-treated cells
that blocked HBV internalization. Data represent two
independent experiments, each comprising three
replicates per condition and are presented as mean ±
SEM. Statistical analysis was performed using a
Mann–Whitney U test (*P ≤ 0.05, **P ≤ 0.01).
Figure 5. SAMHD1 restricts HBV particle genesis.
(A) HepG2.2.15 cells were pretreated with ETV (1 μM) or
vehicle control for 72 h, drug was removed by washing,
and cells transduced with Vpx-LVPs. The cells were
cultured for 72 h and extracellular HBV DNA quantiﬁed
by qPCR. Data represent three independent
experiments that comprised three technical replicates
and are presented asmean ± SEM. SAMHD1 expression is
conﬁrmed by Western blotting. (B) HepG2-NTCP cells
were transduced with Vpx-LVPs 24 h before infecting
with HBV at an MOI of 200. Secreted HBV DNA was
measured at 6 and 10 d postinfection. As before, to
control for nascent particle production, the cells were
treated with 1 μM of entecavir (ETV). Data represent
three independent experiments that comprised three
technical replicates and are presented as mean ± SEM.
Statistical analysis was performed using a
Mann–Whitney U test (*P value ≤ 0.05, **P value ≤ 0.01).
(C)HepG2-NTCP cells were transduced with Vpx-LVP and
24 h later, infected with Ad-HBV-GFP at an MOI of 20.
After 3 d, secreted HBV DNA was measured and SAMHD1
expression assessed by Western blot. Transduced cells
were treated with 1 μM of ETV as a control for nascent
particle production (data not shown). Data represent
three independent experiments and are presented as
mean ± SEM. Statistical analysis was performed using a
Mann–Whitney U test (**P value ≤ 0.01). (D) Wt and
Samhd1 KO cells were transduced with Ad-HBV-GFP at
an MOI of 20 and extracellular HBV DNA was measured
at indicated time points. Particle production per hour
was estimated and values are shown below the graph.
Data represent three independent experiments that
comprised three technical replicates and are presented as mean ± SEM relative to the Wt control. Statistical analysis was performed using a Mann–Whitney U test
(**P value ≤ 0.01). Source data are available for this ﬁgure.
Dual role for SAMHD1 in HBV replication Wing et al. https://doi.org/10.26508/lsa.201900355 vol 2 | no 2 | e201900355 6 of 12
overexpression of SAMHD1 that may perturb the balance of cellular
dNTPs and compromise data interpretation. We noted that pre-
treating HBV producer cells with ETV to reduce intracellular levels of
encapsidated rcDNA before targeting SAMHD1 was required to ob-
serve a signiﬁcant increase in secreted HBV DNA and so thismay also
contribute to the modest phenotype reported in earlier studies. Our
observation that SAMHD1 regulates the production of infectious HBV
particles is of interest, given recent reports that de novo particle
transmission events may be required to maintain the cccDNA pool
(Goyal et al, 2017; Allweiss et al, 2018; Giersch et al, 2019).
Viruses evolve sophisticated means to evade or directly counteract
restriction factors. Our infection experiments have not shown any
perturbation in SAMHD1 expression levels, consistent with a previous
report (Sommer et al, 2016), which is unsurprising, given the key role of
SAMHD1 in cccDNA formation. Of note, HBV infection has been reported
to induce ribonucleotide reductase subunit 2 (RNR-R2) expression via
an HBx-p53–dependent pathway and thereby increase cellular dNTP
levels (Cohen et al, 2010; Ricardo-Lax et al, 2015). We conﬁrmed that
HBV-induced RNR-R2 expression led to an increase in cellular dNTPs
(Fig S9); however, this was not sufﬁcient to overcome SAMHD1 re-
striction of new particle genesis. Because SAMHD1 activity is regulated
via cell cycle–dependent kinases, HBV infection may alter cell cycle
and thereby modulate SAMHD1 restriction. A number of viruses, in-
cluding DNA viruses, RNA viruses, and retroviruses, induce cell cycle
arrest between the G2 and M phases, allowing viral genomes to
replicate before the cell entersmitosis. Humanpapillomavirus induces
G2/Mphase arrest via E4maintenance of Cdk1 phosphorylation (Knight
et al, 2006). Hepatitis C virus induces G2/M arrest of hepatocytes via
antioxidative stress and TGF signaling (Walters et al, 2009; Kannan et al,
2011). Xia et al recently reported that HBV infection arrests hepatocytes
in G2/M cycle (Xia et al, 2018); however, this contrasts with previous
reports showing that HBV replication is independent of the cell cycle in
a transgenic mouse model (Guidotti et al, 1997). HBx protein has been
implicated in deregulating the cell cycle; however, the literature is
conﬂicting and may reﬂect the non-physiological nature of many
studies that used HBx overexpression systems.
In summary, our ﬁndings show that SAMHD1 can regulate multiple
stages of the HBV replication cycle. Its diverse roles in dNTP
metabolism, DNA repair pathways and innate immune activation has
implications for the regulation of many viruses that rely on host
metabolic activities to replicate.
Materials and Methods
Reagents, inhibitors, and antibodies
All tissue culture media and supplements, including fetal calf
serum, were obtained from Invitrogen. All tissue culture plasticware
were purchased from Sarstedt. Entecavir (ETV) was purchased from
Sigma. IFN α was obtained from PeproTech. Myrcludex B was a kind
gift from Stephan Urban. Deoxynucleosides dA (D8668) and dT
(T1895) were purchased from Sigma, and dG (HY-17563) and dT (HY-
17564) from MedChem. The following antibodies were used: mouse
anti-SAMHD1 (ab67820; Abcam); rabbit anti-pSAMHD1 (Cell Signaling
Technology), goat anti RRM2 (Santa Cruz), mouse anti-β Actin
(Sigma), and anti-mouse Alexa 488 (Life Technologies). The SAMHD1
CRISPR construct px458-SAM-sgRNA-1_2 was generated by the
WIMM genome engineering service and guide RNAs designed as
previously reported (Herold et al, 2017).
Cell lines and viruses
HepG2-NTCP (K7) cells were cultured in DMEM supplemented with
100U/ml penicillin, 0.1 mg/ml streptomycin, 10% FCS, GlutaMAX and
nonessential amino acids. Puriﬁed HBV was produced from HepAD38
cells as previously reported (Ko et al, 2018). rHBV reporter virus
expressing Gaussia luciferase (rHBV-GLuc) was generated by stably
transfecting HepG2 cells with a 1.3 HBV genome with a TTR promoter
followed by a Gaussia luciferase gene (pRR_rHBV-TTR-Gaussia) along
with a helper construct for expressing HBV polymerase and surface
proteins (pRR_TTR-Polymerase-LMS-IRES-Puro) as previously re-
ported (Protzer et al, 1999; Untergasser et al, 2006). Lentiviral vectors
expressing Wt SAMHD1 or K11A mutant were produced as described
(Schaller, Pollpeter et al, 2014b). Brieﬂy, 293T cells were transfected
using Fugene HD (Promega UK Ltd) and extracellular media har-
vested at 48 and 72 h post-transfection, ﬁltered through a 0.45-μm
syringe ﬁlter and stored at −80°C. SIVmac containing Vpx virus-like
particles and VSV-G–pseudotyped HIV-1 NL4.3 were produced as
previously described (Goujon et al, 2008).
Generation of Samhd1 KO cells
HepG2-NTCP cells were transfected with 1 μg of the px458-SAM-
sgRNA-1_2 construct using Fugene HD (Promega UK Ltd) according
Figure 6. Proposed role of SAMHD1 in HBV life cycle.
Phosphorylated SAMHD1 plays a key role in HBV rcDNA to cccDNA conversion in
the nucleus of an infected cell as well as regulating innate immune activation
genes such as MxA and APOBECS. In addition, SAMHD1 dNTPase restricts the ability
of viral polymerase to reverse transcribe pgRNA-rcDNA, required for the genesis of
new infectious particles.
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to the manufacturer’s protocol. 48 h post-transfection, the cells
were cloned by limiting dilution, expanded, and individual clones
screened for SAMHD1 expression by Western blot.
HBV infection
HepG2-NTCP cells were seeded on collagen-coated plasticware and
treated with 2.5% DMSO for 3 d before infection. The cells were
infected with HBV at an MOI of 200 genome equivalents per cell in
the presence of 4% polyethylene glycol 8,000 for 24 h. Viral in-
oculum was removed at 24 h postinfection, the cells were washed
three times with PBS and maintained in DMEM 10% FCS supple-
mented with 2.5% DMSO.
Synchronized HBV infection
HepG2-NTCP cells were treated with 2.5% DMSO for 3 d before
infection and the cells chilled on ice for 15 min before infecting with
the chilled viral inoculum. The cells were incubated at 4°C for 1 h
and then transferred to 37°C for 6 h. Non-internalized virus was
removed by treating with trypsin for 3 min followed by three washes
with PBS. The cells were harvested and HBV DNA measured by
quantitative PCR (qPCR) as described below. As a control, the cells
were pretreated with heparin (50 IU/ml) for 1 h to block HBV uptake
as previously reported (Schulze et al, 2007).
HBV genome transfer using an adenovirus vector
Ad-HBV-GFP was prepared in 293T cells as described (Sprinzl et al,
2001) and HepG2-NTCP cells infected at 80% conﬂuency at anMOI of
20 Focus Forming Units (FFU)/cell. Transduced cells were moni-
tored for their secretion of HBV DNA and RT-dependency conﬁrmed
by treating cells with entecavir (1 μM) (Fig S7).
PCR quantiﬁcation of HBV DNA and RNA
Total cellular DNA and RNA were extracted from HBV-infected cells
using the All-Prep-DNA and RNA kit (QIAGEN). Selective PCR of
cccDNA was performed as described (Ko et al, 2018). Brieﬂy,
extracted DNA was treated with 5U of T5 exonuclease (NEB) for 37°C
for 30 min followed by heat inactivation at 95°C. Treated DNA
samples were ampliﬁed in a SYBR green qPCR reaction (PCR Bio-
systems) (see Table S1 for primer sequences). For HBV DNA
quantiﬁcation, a 10-fold dilution series of an external HBV plasmid
was used. HBV pgRNA was quantiﬁed from DNase-treated RNA
extracts using a one-step reverse transcriptase qPCR (RT-qPCR) kit
(Takyon). HBV primer probes (FAM) were used to amplify pgRNA,
with primer probes for β 2 microglobulin (VIC) used as an internal
control in a multiplexed RT-qPCR reaction. To quantify extracellular
HBV from infected cells, supernatants were ﬁrst DNase-digested
with 1U of DNase at 37°C for 30 min (Thermo Fisher Scientiﬁc) to
remove any non-virion–associated HBV DNA. DNase was sub-
sequently inactivated by the addition of 1 mM EDTA. A 2× lysis buffer
containing 0.1 M Tris–HCl (pH7.4), 50 mM KCl, 0.25% Triton X-100, and
40% glycerol was added to the digested supernatants. Lysates were
used in a qPCR reaction to detect HBV rcDNA using speciﬁc primers
HBV4F and HBV4R (Tropberger et al, 2015). Copy numbers were
calculated using a dilution series of an external HBV plasmid as
before. All qPCR reactions were carried out on a Roche 96 Light-
Cycler (Roche).
Southern blot detection of HBV DNA
To detect HBV DNA forms, including cccDNA, DNA from HBV-infected
cells was isolated using an HIRT extraction protocol and separated
by agarose gel as previously reported (Yan et al, 2012; Ko et al, 2018).
DNA was transferred to a nylon membrane and hybridized with a
digoxigenin-labeled full-length HBV probe. Luminescent signal was
detected using the DIG Luminescent Detection Kit (Roche).
SDS–PAGE and Western blots
The cells were lysed in RIPA buffer (20 mM Tris, pH 7.5, 2 mM EDTA,
150 mM NaCl, 1% NP40, and 1% sodium deoxycholate) supple-
mentedwith protease inhibitor cocktail tablets (Roche). 4× reducing
buffer was added to samples before incubating at 95°C for 5 min.
Proteins were separated on a 10% polyacrylamide gel and transferred
to PVDF membranes (Amersham). The membranes were blocked in
PBST, 5% skimmed milk (Sigma), and proteins detected using speciﬁc
primary and HRP-secondary antibodies. Protein bands were detected
using Pierce SuperSignal West Pico chemiluminescent substrate kit
(Pierce) and images collected with a PXi Touch gel and membrane
Imaging system (Syngene).
Measurement of deoxynucleoside triphosphate levels in cells
Assays were performed as previously reported (Wilson et al, 2011).
Brieﬂy, reactions contained 100 pmol of NDP-1 primer (59-
CCGCCTCCACCGCC-39), probe (59-6FAM/AGGACCGAG/ZEN/GCAAGA-
GCGAGCGA/IBFQ-39), and 150 pmol of the template (59-TCGCTCGC-
TCTTGCCTCGGTCCT/BHQ-1/AGCGGCGGTGGAGGCG G-39). Non-limiting
dNTPs were added to a ﬁnal concentration of 100 μM (except the
dNTP to bemeasured). GoTaq Hot Start was added at a concentration
of 0.5 U per reaction with 5× Colorless GoTaq Flexi Buffer and MgCl2 at
a ﬁnal concentration of 1.5 mM. Reactions were made up to 10 μl with
nuclease-free water, the volume of which was adjusted to in-
corporate 2 μl of cell extract. Reactions were performed on a Roche
96 LightCycler (Roche). The thermal proﬁle consisted of 3 min at 95°C
and a primer extension time of 64°C for 20 min. Raw ﬂuorescence
readings for the 6-FAM ﬁlter were measured every 30 s and analyzed
using Microsoft Excel (Microsoft) and Prism 7 (GraphPad Software).
Immunoﬂuorescence
The cells were plated on glass coverslips, washed with PBS, and
ﬁxed with 4% paraformaldehyde for 20 min at room temperature.
The coverslips were treated with 10 mM NH4Cl for 10 min at room
temperature followed by PBS 0.1% (vol/vol) Triton-X for 5min on ice.
The coverslips were blocked, and incubated with the primary an-
tibody (1:200) for 1 h at room temp, before washing and incubated
with 488-conjugated secondary antibody (1:1,000). The coverslips
were counterstained with 49,6-diamidino-2-phenylindole and moun-
ted with Prolong Gold Antifade (Invitrogen). The slides were viewed on
a Zeiss ﬂuorescence microscope (Carl Zeiss AG, DE).
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RPA32 staining
HepG2-NTCP cells were cultured on glass coverslips, treated with
1 μM CPT (Sigma) for 4 h, permeabilized with nuclear extraction
buffer (10 mM PIPES, 20 mM NaCl, 3 mM MgCl2, 300 mM sucrose, and
0.5% Triton X-100) for 5 min on ice before ﬁxing in 3.6% para-
formaldehyde for 10 min at room temperature. The cells were
washed three times with PBS and blocked with ADB for 1 h at 4°C
and incubated with anti-Replication Protein A2 (PA32) RPA32 (Cat.
No. NA18; Millipore) and anti-P-RPA (S4/8) (Cat. No. A300-245A;
Bethyl Laboratories) antibodies (diluted in ADB) for 1 h at room
temperature. Unbound antibody was removed by washing with PBS
and cells counterstained with Alexa Fluor–conjugated secondary
antibodies (diluted in ADB). Finally, the cells were washed twice
with ADB and coverslipsmounted onto glass slides with Vectashield
mounting agent containing 0.4 μg/ml DAPI (Vectashield). Images
were taken using a Nikon Eclipse Ni microscope equipped with a
60× oil lens and at least 200 cells quantiﬁed per condition.
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
201900355.
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